SSL Secure
NAD+NAD+ for anxietyNAD+ for depressionNAD+ mental health

NAD+ for Anxiety & Depression: Mental Health Benefits Guide

Discover how NAD+ for anxiety may reduce symptoms: the science behind NAD+ therapy for depression and mental health. Protocols and what to expect.

Published January 15, 2026Updated April 8, 20269 min read

Written by

Glunova Medical Team

Clinical Research & Health Content

Editorially reviewed by

Glunova Medical Review Board

Medical Advisory Panel

This guide is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Review medication, dosing, and handling decisions with a licensed healthcare professional.
## A Conversation We Need to Have About NAD+ and Mental Health If you have been searching for answers beyond conventional antidepressants and anti-anxiety medications, you are not alone. Roughly 30% of people with major depression do not respond adequately to first-line pharmacotherapy, according to data published in *The Lancet Psychiatry*. That statistic is what drives researchers to look at the problem from a different angle, and NAD+ has quietly emerged as one of the most intriguing candidates. We want to be upfront: NAD+ is not an FDA-approved treatment for anxiety or depression. But the preclinical and early clinical evidence is compelling enough that we believe you should understand it, discuss it with your care team, and make an informed choice. ## Why Your Brain Runs Low on Fuel Your brain weighs about three pounds, yet it burns roughly 20% of all the energy your body produces. That energy comes from mitochondria, and those mitochondria depend on NAD+ to convert glucose into ATP. A 2019 review in *Cell Metabolism* established that NAD+ levels in neural tissue decline sharply with age, and that this decline correlates with cognitive impairment and mood dysregulation. When brain cells cannot generate enough ATP, several downstream problems emerge. Neurotransmitter production slows down because serotonin and dopamine both require energy-intensive enzymatic steps. Neuroinflammation increases because sirtuins, the NAD+-dependent enzymes that normally keep inflammatory pathways like NF-kB in check, lose their fuel. And DNA repair stalls as PARP enzymes compete with sirtuins for the same shrinking NAD+ pool. A 2021 study in *Frontiers in Neuroscience* showed that elevated neuroinflammation is present in roughly 25 to 30% of patients with treatment-resistant depression, suggesting that addressing cellular energy and inflammation could be a missing piece. ## The Research So Far ### What Animal Studies Show Multiple preclinical studies have demonstrated that boosting NAD+ through precursors like NMN and NR reduces depression-like and anxiety-like behaviors in rodent models. Mice given NMN showed increased hippocampal BDNF expression, a marker strongly linked to antidepressant response in humans. ### What Human Data Suggests A 2018 study in *Nature Communications* confirmed that oral nicotinamide riboside supplementation was well-tolerated in middle-aged and older adults and successfully elevated blood NAD+ levels. A 2021 review in *Nature Reviews Molecular Cell Biology* further detailed how NAD+ metabolism influences virtually every cellular process relevant to brain health. While large mood-focused trials have not been completed, clinical observations from integrative medicine practitioners consistently report improvements in mental clarity, emotional resilience, sleep quality, and physical energy. ### Where the Evidence Stands (March 2026) | Evidence Level | What We Know | |---------------|-------------| | Strong mechanistic support | NAD+ fuels neurotransmitter synthesis and reduces neuroinflammation | | Consistent preclinical data | NAD+ precursors reduce depression-like behavior in animal models | | Emerging human data | Subjective improvements in energy, clarity, and well-being | | Still needed | Large-scale RCTs focused on depression and anxiety outcomes | ## How NAD+ May Ease Anxiety Anxiety is fundamentally a state of neural hyperactivation. The brain perceives threats, real or imagined, and mobilizes a stress response that includes cortisol release, sympathetic nervous system firing, and reduced parasympathetic tone. NAD+ may modulate this cycle through several mechanisms. First, restoring cellular energy balance helps because anxious brains are paradoxically energy-depleted. Second, NAD+-dependent enzymes participate in GABA regulation, the brain's primary calming neurotransmitter. Third, sirtuin activation through adequate NAD+ quiets neuroinflammatory pathways. And finally, NAD+ supports circadian rhythm through SIRT1 activity, helping break the vicious cycle between poor sleep and anxiety. Patients often describe the benefit as feeling "less reactive." Stressors that previously triggered racing thoughts or chest tightness feel more manageable. | Timeframe | What Patients Typically Report | |-----------|-------------------------------| | Week 1-2 | Slightly calmer baseline, better stress tolerance | | Week 3-4 | Reduced frequency of racing thoughts | | Month 2-3 | Noticeably improved emotional regulation | | Month 3+ | Sustained, stable benefits when maintained consistently | ## How NAD+ May Ease Depression Depression is not a single condition. Some people experience it through neurotransmitter imbalance, others through inflammation, metabolic dysfunction, or chronic fatigue. NAD+ therapy may be particularly relevant for the latter categories. Serotonin and dopamine synthesis both require adequate cellular energy that NAD+ restores. BDNF production supports neuroplasticity, the same mechanism targeted by ketamine therapy. Circadian rhythm regulation through SIRT1 corrects disrupted sleep-wake patterns. And anti-inflammatory sirtuin activation addresses the subset of depression characterized by elevated inflammatory markers. The patients who see the most dramatic benefit tend to be those whose primary symptoms include profound fatigue, brain fog, and difficulty concentrating rather than those whose depression is primarily psychological. ## Practical NAD+ Protocols for Mental Health Based on clinical practice patterns as of March 2026: **Phase 1: Loading (Weeks 1-2)** - IV infusion: 250 to 500mg, two to four sessions - Alternative: Subcutaneous injection 100 to 150mg daily **Phase 2: Therapeutic (Weeks 3-8)** - IV: 500mg once weekly - Alternative: SubQ 150 to 200mg, three times weekly **Phase 3: Maintenance (Ongoing)** - IV: 250 to 500mg monthly - Alternative: SubQ 100 to 150mg, two to three times weekly **A practical tip we share with patients:** Start at the lower end of these ranges, especially if you are also taking psychiatric medications. NAD+ can have an energizing effect, and too high a dose too quickly can temporarily increase restlessness. ## What Works Best Alongside NAD+ We consistently see the best outcomes when patients combine NAD+ with complementary approaches: | Complementary Approach | Why It Helps | |----------------------|-------------| | Cognitive behavioral therapy (CBT) | NAD+ enhances neuroplasticity, making therapy more effective | | Regular aerobic exercise | Exercise independently boosts both NAD+ and BDNF | | Sleep optimization | Better sleep supports mood and NAD+ circadian rhythm | | Omega-3 supplementation | Anti-inflammatory, supports neuronal membrane integrity | | Mindfulness meditation | Both NAD+ and meditation reduce NF-kB-driven inflammation | Supporting nutrients that pair well include B-complex vitamins, magnesium, and vitamin D. ## Critical Safety Points **NAD+ is NOT a substitute for** professional mental health treatment, prescribed psychiatric medications, therapy, or crisis intervention. **When to use caution:** If you have bipolar disorder, NAD+ may trigger hypomanic episodes in some individuals. If you are in acute crisis, seek immediate professional help. If you take MAOIs, consult your provider about potential interactions. ## The Bottom Line NAD+ therapy represents a genuinely promising complementary approach to anxiety and depression, working at the level of cellular energy, neuroinflammation, and neurotransmitter support. The mechanistic evidence is strong and early clinical observations are consistently positive. But large-scale human trials have not been completed, so the responsible path is to discuss it with your mental health provider, start conservatively, and track your response over at least 8 to 12 weeks. *This article is for educational purposes only. If you are experiencing a mental health crisis, contact the 988 Suicide and Crisis Lifeline. Always work with qualified mental health professionals.* For more information, see our guide on [NAD+ injection benefits](/guides/nad-injection-benefits-anti-aging-energy-recovery-guide). Learn more about [NAD+ for brain health](/guides/nad-for-brain-health-cognitive-function-memory) to enhance your understanding. You may also find our article on [NAD+ for sleep quality](/guides/nad-for-sleep-quality-improvement-guide) helpful. Our detailed guide on [NAD+ for addiction recovery](/guides/nad-for-addiction-recovery-detox-guide) covers this topic in depth. Explore our resource on [NAD+ side effects and safety](/guides/nad-side-effects-safety-what-to-expect) for additional insights. For a deeper dive, check out [proper NAD+ dosage](/guides/nad-plus-dosing-guide-how-much-to-take). --- ## References - [NAD+ in Brain Aging and Neurodegenerative Disorders](https://doi.org/10.1016/j.cmet.2019.09.001). *Cell Metabolism*, 2019. - [Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults](https://doi.org/10.1038/s41467-018-03421-7). *Nature Communications*, 2018. - [The Role of Neuroinflammation in the Pathophysiology of Major Depressive Disorder](https://doi.org/10.3389/fnins.2021.659486). *Frontiers in Neuroscience*, 2021. - [NAD+ metabolism and its roles in cellular processes during ageing](https://doi.org/10.1038/s41580-020-00313-x). *Nature Reviews Molecular Cell Biology*, 2021. - [Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling](https://doi.org/10.1016/j.tibs.2012.07.004). *Trends in Biochemical Sciences*, 2012.

Frequently Asked Questions

Sources & References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5